02171nam 2200553Ia 450 991045032440332120200520144314.00-309-54976-0(CKB)1000000000030478(EBL)3377918(SSID)ssj0000672895(PQKBManifestationID)11453482(PQKBTitleCode)TC0000672895(PQKBWorkID)10642671(PQKB)11173260(MiAaPQ)EBC3377918(Au-PeEL)EBL3377918(CaPaEBR)ebr10078111(OCoLC)923274023(EXLCZ)99100000000003047820050524d2005 uy 0engur|n|---|||||txtccrFederal agency roles in cancer drug development from preclinical research to new drug approval[electronic resource] the National Cancer Institute and the Food and Drug Administration /Joseph P. Newhouse, John Mendelsohn, Hellen Gelband and Roger Herdman3rd ed.Washington, D.C. National Academy Pressc20051 online resource (69 p.)Description based upon print version of record.0-309-09639-1 ""FRONT MATTER""; ""Table of Contents""; ""1 SCIENTIFIC RATIONALE""; ""2 THE NATIONAL CANCER INSTITUTE""; ""3 THE FOOD AND DRUG ADMINISTRATION""; ""4 SUMMARY: THE ROLES OF THE NCI AND FDA IN DEVELOPING ANTICANCER AGENTS""; ""REFERENCES""; ""ACRONYMS AND ABBREVIATIONS""Antineoplastic agentsDevelopmentPublic administrationUnited StatesElectronic books.Antineoplastic agentsDevelopment.Public administrationNewhouse Joseph P145731Mendelsohn John M979904Gelband Hellen950440Herdman Roger858063MiAaPQMiAaPQMiAaPQBOOK9910450324403321Federal agency roles in cancer drug development from preclinical research to new drug approval2234867UNINA